Lp(a) apheresis and CVD risk modulation
Lp(a) meeting Elisa Waldmann shows prospective data on reduced CV event rates after regular of Lp(a) apheresis in patients with high baseline Lp(a) levels and emphasizes the need of randomized controlled data.
This lecture by Elisa Waldmann was part of the EAS-endorsed satellite meeting "The imminent danger of Lp(a): Time to face the challenge" held prior to the 87th EAS congress in Maastricht
Elisa Waldmann, MD - Medical Department of the Ludwig Maximilians University, Munich, Germany
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: